Mission Statement, Vision, & Core Values of Myomo, Inc. (MYO)

Ever wondered what drives a company that's making strides in medical robotics? What are the guiding principles behind Myomo, Inc.'s mission to improve the lives of individuals with upper-limb paralysis? With a 69% increase in revenue to $32.6 million in 2024, how does their vision translate into tangible results?

Dive in to explore the mission statement, vision, and core values that shape Myomo's path, and discover how these elements contribute to their goal of becoming the worldwide standard of care, especially after a transformational year where quarterly revenue surpassed $12 million.

Myomo, Inc. (MYO) An Overview of

Myomo, Inc. is a commercial-stage medical robotics company focused on restoring function for individuals with upper extremity paralysis. The company designs, manufactures, and markets the MyoPro orthosis, a powered brace that helps restore function to paralyzed or weakened arms and hands, enabling individuals to perform activities of daily living. As of April 2025, Myomo continues to expand its reach through direct sales, partnerships with rehabilitation clinics, and collaborations with Veterans Affairs (VA) hospitals.

Myomo's MyoPro is the flagship product. It is a myoelectric-controlled upper extremity orthosis designed to help people regain the ability to use their arms and hands following a stroke, spinal cord injury, or other neuromuscular conditions. The device works by reading faint EMG signals from the surface of the skin and translates them into movement of the arm and hand. This technology allows users to perform functional tasks such as feeding themselves, reaching for objects, and carrying items, significantly improving their independence and quality of life.

Myomo has demonstrated significant financial achievements in its latest reporting period. In 2024, Myomo reported record revenue, driven primarily by increases in MyoPro unit sales. The company has also seen growth in key markets, particularly through its work with the VA system and expansion into new international markets.

Here are some highlights of Myomo's recent financial performance:

• Record Revenue: Achieved record revenue in 2024, reflecting strong demand for the MyoPro device.
• Increased Unit Sales: Saw a significant increase in the number of MyoPro units sold, indicating growing market adoption.
• Market Expansion: Expanded its presence in key markets, including increased penetration within the VA system and growth in international sales.

Myomo stands as a leader in the medical robotics field, offering innovative solutions for upper extremity paralysis. To delve deeper into Myomo's potential and understand the factors driving its success, explore the following resource: Exploring Myomo, Inc. (MYO) Investor Profile: Who’s Buying and Why?

Myomo, Inc. (MYO) Mission Statement

Myomo, Inc. focuses on restoring movement and independence to individuals affected by neurological disorders. The company's mission is centered around developing and offering innovative medical solutions that improve the quality of life for patients with conditions such as stroke, spinal cord injury, and brachial plexus injury. Myomo aims to empower these individuals to regain functional use of their limbs, enhance their mobility, and participate more fully in daily activities.

Myomo's commitment to innovation, patient-centricity, and clinical excellence drives its efforts to create advanced technologies and personalized therapy programs. The company collaborates with healthcare professionals, researchers, and advocacy groups to advance the field of rehabilitation and expand access to its life-changing solutions. By prioritizing patient outcomes and continuous improvement, Myomo strives to be a leader in the development and delivery of assistive medical devices that make a meaningful difference in the lives of those they serve.

Core components of Myomo's mission statement include:

• Restoring Movement and Independence: Myomo's primary goal is to help individuals with neurological disorders regain lost motor function and increase their independence in daily living.
• Innovative Medical Solutions: Myomo is committed to developing and offering cutting-edge medical technologies that address the unique needs of patients with upper-extremity paralysis.
• Improving Quality of Life: Myomo's mission extends beyond physical rehabilitation to encompass the emotional, social, and psychological well-being of its patients.

Restoring Movement and Independence is at the heart of Myomo's mission. The company's myoelectric orthoses are designed to detect and interpret a patient's own muscle signals, translating them into functional movements of the paralyzed or weakened limb. This technology enables individuals to perform tasks they previously thought impossible, such as eating, dressing, and writing. By restoring movement, Myomo empowers patients to regain control over their lives and participate more fully in activities that are meaningful to them.

Myomo is dedicated to creating innovative medical solutions that push the boundaries of rehabilitation technology. The company's research and development efforts are focused on developing advanced myoelectric control algorithms, lightweight and comfortable orthotic designs, and personalized therapy programs that maximize patient outcomes. Myomo collaborates with leading research institutions and clinical centers to validate the effectiveness of its technologies and identify new applications for its devices.

Myomo's mission extends beyond physical rehabilitation to focus on improving the quality of life for its patients. The company recognizes that neurological disorders can have a profound impact on an individual's emotional, social, and psychological well-being. Myomo's solutions are designed to not only restore physical function but also enhance self-esteem, reduce social isolation, and improve overall life satisfaction. By empowering patients to regain independence and participate more fully in daily activities, Myomo helps them to live more fulfilling and meaningful lives.

Myomo's commitment to delivering high-quality products and services is supported by rigorous clinical research and patient outcomes data. According to a study published in the Journal of NeuroEngineering and Rehabilitation, patients who used Myomo's myoelectric orthoses experienced a 40% improvement in upper-extremity function compared to those who received traditional rehabilitation therapy alone. These findings demonstrate the significant impact that Myomo's technologies can have on patient outcomes.

Furthermore, Myomo is dedicated to expanding access to its life-changing solutions through strategic partnerships with healthcare providers, payers, and advocacy groups. The company actively works to raise awareness of the benefits of myoelectric orthotics and advocate for policies that support patient access to these technologies. By collaborating with key stakeholders, Myomo strives to ensure that individuals with upper-extremity paralysis have the opportunity to benefit from its innovative medical devices and personalized therapy programs.

Myomo, Inc. (MYO) Vision Statement

While direct access to Myomo, Inc.'s official vision statement as of April 2025 is not available, we can analyze their mission, core values, and strategic objectives to infer their overarching vision. This approach provides a comprehensive understanding of the company's aspirations and direction.

Mission Statement: Myomo's mission is centered around restoring function and independence to individuals affected by neurological disorders. They achieve this by designing, manufacturing, and marketing innovative medical devices, specifically myoelectric orthotics. These devices empower individuals with upper-extremity paralysis to regain movement and participate more fully in daily life. This commitment is reflected in their focus on:

• Innovation: Continuously developing and improving myoelectric technology.
• Empowerment: Enabling users to perform activities of daily living.
• Independence: Reducing reliance on caregivers.

Core Values: Although specific core values are not explicitly stated, Myomo's actions and communications suggest a commitment to:

• Patient-centricity: Prioritizing the needs and well-being of their users.
• Quality: Maintaining high standards in product design and manufacturing.
• Integrity: Operating ethically and transparently.
• Innovation: Continuously seeking advancements in their field.

Strategic Objectives: Myomo's strategic objectives, as evidenced by their recent activities and investor presentations, include:

• Expanding Market Reach: Increasing the availability of MyoPro devices to a wider patient population.
• Driving Reimbursement: Securing favorable insurance coverage for their products.
• Technological Advancement: Investing in research and development to enhance device functionality and user experience.
• Building Partnerships: Collaborating with healthcare providers and rehabilitation centers to promote adoption.

Based on these elements, we can infer Myomo's vision statement as aspiring to be the global leader in myoelectric orthotics, transforming the lives of individuals with upper-extremity paralysis by restoring their function, independence, and quality of life. This vision is supported by their financial performance. Myomo reported revenue of $17.2 million for the year ended December 31, 2023, an increase of 26% compared to $13.7 million for the year ended December 31, 2022. Gross profit for the year ended December 31, 2023 was $9.2 million, or 53.5% of revenue, compared with gross profit of $7.2 million, or 52.4% of revenue, for the year ended December 31, 2022.

Furthermore, Myomo's commitment extends beyond technological advancement. They actively engage with the patient community, providing support and resources to help individuals navigate their journey to recovery. This holistic approach underscores their dedication to improving the overall well-being of their users.

To gain more insights into Myomo and its investors, check out this resource: Exploring Myomo, Inc. (MYO) Investor Profile: Who’s Buying and Why?

Myomo, Inc. (MYO) Core Values of

While specific details about Myomo, Inc.'s (MYO) mission statement, vision, and core values as of April 2025 are not available, we can analyze the company's behavior and reported activities to infer what these guiding principles might be. Based on available information, here's an interpretation of what Myomo's core values likely encompass:

Here's a possible look at Myomo's core values:

• Patient-Centricity: A deep commitment to improving the lives of individuals with neurological conditions.
• Innovation: Relentless pursuit of cutting-edge technology to enhance rehabilitation and mobility.
• Empowerment: Enabling patients to regain independence and improve their quality of life.
• Integrity: Maintaining the highest ethical standards in all aspects of the business.
• Collaboration: Working closely with healthcare professionals, researchers, and the patient community.

Patient-Centricity:

Myomo's core appears to revolve around a deep commitment to improving the lives of individuals, especially children, with neurological conditions and upper-extremity paralysis. This is evidenced by their focus on developing and providing innovative medical devices like the MyoPro. The company's work with children, highlighted in various news articles, underscores a dedication to enhancing the quality of life for even the youngest patients. This patient-first approach likely permeates all aspects of their operations, from product development to customer support.

For example, Myomo provides personalized support and training to patients and therapists, ensuring that the MyoPro is effectively integrated into their rehabilitation programs. This hands-on approach demonstrates a commitment to patient success and optimal outcomes.

Innovation:

Innovation is likely a central value, driving Myomo's development of advanced technologies for rehabilitation. The MyoPro itself, a powered brace that restores function to paralyzed arms and hands, is a testament to this commitment. The company continuously seeks to refine and expand its product offerings, aiming to provide more effective and user-friendly solutions. This dedication to innovation is likely reflected in their investments in research and development, as well as their collaborations with leading medical institutions.

Empowerment:

Empowering patients to regain independence and improve their quality of life is a key value. Myomo's MyoPro device is designed to enable individuals with upper-extremity paralysis to perform everyday tasks, such as feeding themselves and carrying objects, which would otherwise be impossible. By restoring function and mobility, Myomo empowers patients to participate more fully in their lives and reduces their reliance on caregivers. This focus on empowerment is likely a driving force behind the company's mission and product development efforts.

Collaboration:

Myomo likely values collaboration, recognizing that working closely with healthcare professionals, researchers, and the patient community is essential for success. The company partners with hospitals, rehabilitation centers, and therapists to integrate the MyoPro into treatment programs and provide comprehensive support to patients. They also engage with patient advocacy groups and participate in research studies to advance the understanding and treatment of upper-extremity paralysis. This collaborative approach ensures that Myomo's products and services are aligned with the needs of patients and healthcare providers.

To learn more about Myomo, explore this insightful resource: Exploring Myomo, Inc. (MYO) Investor Profile: Who’s Buying and Why?